Trial Profile
A Phase II Randomised, Double-Blind, Placebo Controlled, Cross-Over Study to Investigate the Efficacy of Mexiletine in Patients with Non-Dystrophic Myotonia. [IMPIEGO DELLA MEXILETINA NELLE MIOTONIE NON DISTROFICHE: SPERIMENTAZIONE CLINICA DI FASE II (IND # 77,021)]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2019
Price :
$35
*
At a glance
- Drugs Mexiletine (Primary)
- Indications Myotonia
- Focus Therapeutic Use
- 18 Jul 2019 Status changed from recruiting to completed.
- 07 Jul 2012 Additional trial location added as reported by European Clinical Trials Database.
- 08 Jun 2011 New trial record